Previous studies have shown that the expression of NOLC1 increases in non-small cell lung cancer, promoting multidrug resistance (MDR), and that its downregulation sensitizes MDR cells [42]. The gene discussed is NOLC1; the disease is non-small cell lung carcinoma.